Source:http://linkedlifedata.com/resource/pubmed/id/19322208
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2009-7-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1476-5551
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1342-3
|
pubmed:meshHeading |
pubmed-meshheading:19322208-Antimetabolites, Antineoplastic,
pubmed-meshheading:19322208-Azacitidine,
pubmed-meshheading:19322208-Child,
pubmed-meshheading:19322208-Female,
pubmed-meshheading:19322208-Humans,
pubmed-meshheading:19322208-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:19322208-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia.
|
pubmed:publicationType |
Letter,
Case Reports
|